您当前的位置：
首页 >
文章列表页 >
Rapid health technology assessment of carfilzomib in the treatment of multiple myeloma
更新时间：2026-05-14

    • Rapid health technology assessment of carfilzomib in the treatment of multiple myeloma

    • ZHONGGUO YAOFANG   Vol. 37, Issue 9, Pages: 1222-1228(2026)

    • DOI：10.6039/j.issn.1001-0408.2026.09.20    

      CLC： R979.1;R551.3

    • Received：13 October 2025，

      Revised：2026-03-25，

      Accepted：25 March 2026，

      Published：15 May 2026

    移动端阅览

  • FENG Zhen,LAI Ran.Rapid health technology assessment of carfilzomib in the treatment of multiple myeloma[J].ZHONGGUO YAOFANG,2026,37(09):1222-1228. DOI： 10.6039/j.issn.1001-0408.2026.09.20.

  •  
  •  

0

Views

6

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Analysis of current situation of researches on comprehensive evaluation of drugs in China based on CiteSpace
Rapid Health Technology Assessment of Donepezil in the Treatment of Alzheimer ’s Disease
Rapid Health Technology Assessment of Albumin-bound Paclitaxel in the Treatment of Breast Cancer
Effectiveness，Safety and Economy of Evolocumab in the Treatment of Hypercholesterolemia ：A Rapid Health Technology Assessment
Rapid Health Technology Assessment of Tirofiban in the Treatment of Acute Coronary Syndrome

Related Author

XIAO Misu
ZHANG Jianping
YANG Quanjun
GUO Cheng
ZHANG Tian
LI Ting
WU Lili
PEI Yifang

Related Institution

Dept. of Anesthesiology， the Affiliated Hospital of Xuzhou Medical University
Dept. of Dermatology， the Affiliated Hospital of Xuzhou Medical University
The First Clinical Medical College， Henan University of Chinese Medicine
Dept. of Spleen， Stomach and Hepatobiliary Disease， the First Affiliated Hospital of Henan University of CM
Dept. of Dermatology，the First Affiliated Hospital of Nanyang Medical College
0